CLDN3 and multiminicore myopathy: A ceRNA regulatory network was established to explore potential therapeutic targets in MMD, leading to the identification of AKT1, CLDN3, ISG20, and TGFB2 as critical hypoxia-immune–related genes implicated in disease mechanisms.